MedTrace Logo

EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan

NCT03579732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4710504

Last updated 2020-09-29

No results posted yet for this study

Summary

The study evaluates the protective effect of low-dose aspirin use on gastrointestinal cancers (colorectal, esophageal and gastric cancers) in long-term users, episodic users and non-users of aspirin in Taiwan.

Conditions

  • Colorectal Neoplasms

Interventions

DRUG

Aspirin (Acetylsalicylic Acid, BAYE4465)

Low dose of aspirin, i.e. \< 150 mg daily

OTHER

No drug

Non-consumers

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03579732 on ClinicalTrials.gov